PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
TRUZX
Price
$62.00
Change
+$0.74 (+1.21%)
Updated
Jun 2 closing price
Net Assets
14.19B
Interact to see
Advertisement

PMBCX vs TRUZX

Header iconPMBCX vs TRUZX Comparison
Open Charts PMBCX vs TRUZXBanner chart's image
PMBCX vs TRUZX Comparison Chart in %
View a ticker or compare two or three
VS
PMBCX vs. TRUZX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBCX is a Buy and TRUZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. TRUZX (14.2B). PMBCX (0.00) and TRUZX (0.00) have matching dividends . PMBCX was incepted earlier than TRUZX: PMBCX (19 years) vs TRUZX (6 years). PMBCX (1.71) is less costly to investors than TRUZX (0.64). TRUZX is a more actively managed with annual turnover of: 92.80 vs. PMBCX (13.70). TRUZX has a lower initial minimum investment than PMBCX: TRUZX (0) vs PMBCX (1000). TRUZX annual gain was more profitable for investors over the last year : 15.67 vs. PMBCX (-15.11). PMBCX return over 5 years is better than : -9.16 vs. TRUZX (-25.44).
PMBCXTRUZXPMBCX / TRUZX
Total Expense Ratio1.710.00-
Annual Report Gross Expense Ratio1.710.64267%
Fund Existence19 years6 years-
Gain YTD-7.25214.078-52%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets24.6B14.2B173%
Annual Yield % from dividends0.000.00-
Returns for 1 year-15.1115.67-96%
Returns for 3 years9.9716.7759%
Returns for 5 years-9.16-25.4436%
Returns for 10 years53.20N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity